Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $405000.0.

  • Envoy Medical's Cost of Revenue rose 279.19% to $405000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 503.18%. This contributed to the annual value of $1.7 million for FY2024, which is 408.16% up from last year.
  • As of Q3 2025, Envoy Medical's Cost of Revenue stood at $405000.0, which was up 279.19% from $361000.0 recorded in Q2 2025.
  • Envoy Medical's Cost of Revenue's 5-year high stood at $538000.0 during Q4 2022, with a 5-year trough of $106000.0 in Q3 2022.
  • Its 4-year average for Cost of Revenue is $397538.5, with a median of $394000.0 in 2024.
  • Per our database at Business Quant, Envoy Medical's Cost of Revenue surged by 27641.51% in 2023 and then crashed by 2736.42% in 2025.
  • Over the past 4 years, Envoy Medical's Cost of Revenue (Quarter) stood at $538000.0 in 2022, then fell by 4.65% to $513000.0 in 2023, then increased by 0.97% to $518000.0 in 2024, then dropped by 21.81% to $405000.0 in 2025.
  • Its Cost of Revenue was $405000.0 in Q3 2025, compared to $361000.0 in Q2 2025 and $358000.0 in Q1 2025.